Related Experiment Videos
Oral acyclovir prevents herpes simplex virus-associated erythema multiforme
The British Journal of Dermatology
|January 1, 1987
Summary
Long-term oral acyclovir successfully prevented recurrent herpes simplex episodes and associated erythema multiforme in a young woman. This treatment offers a potential solution for managing this complex dermatological condition.
Area of Science:
- Dermatology
- Virology
- Immunology
Background:
- Recurrent erythema multiforme (EM) is a hypersensitivity reaction often triggered by infections, particularly herpes simplex virus (HSV).
- Managing recurrent HSV infections and their associated EM can be challenging, requiring effective long-term therapeutic strategies.
Observation:
- A case study of a young woman experiencing frequent gluteal herpes simplex outbreaks leading to erythema multiforme is detailed.
- The patient presented with a history of recurring episodes of both conditions, significantly impacting her quality of life.
Findings:
- Sustained oral acyclovir therapy was administered to the patient.
- This long-term treatment regimen effectively suppressed HSV reactivation, thereby preventing subsequent erythema multiforme episodes.
Implications:
- Long-term oral acyclovir demonstrates significant efficacy in preventing both herpes simplex virus recurrence and associated erythema multiforme.
- This case highlights the importance of antiviral prophylaxis in managing complex dermatological conditions linked to viral infections.
- The findings suggest a potential therapeutic approach for similar patient cases, improving patient outcomes and reducing disease burden.